|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
4218695 |
| 003 |
ICU |
| 005 |
20030529153800.0 |
| 008 |
990723s2000 nyua b 001 0 eng c |
| 010 |
|
|
|a 99039513
|
| 020 |
|
|
|a 0824763998 (alk. paper)
|
| 035 |
|
|
|a 99039513
|
| 035 |
|
|
|a (DNLM)100892784
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d NhCcYBP
|d OrLoB-B
|d OCoLC
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC280.B6
|b T86 2000
|
| 060 |
1 |
0 |
|a WE 258
|b T924 2000
|
| 082 |
0 |
0 |
|a 616.99/271
|2 21
|
| 245 |
0 |
0 |
|a Tumor bone diseases and osteoporosis in cancer patients :
|b pathophysiology, diagnosis, and therapy /
|c edited by Jean-Jacques Body.
|
| 260 |
|
|
|a New York :
|b Marcel Dekker,
|c c2000.
|
| 300 |
|
|
|a xvii, 561 p. :
|b ill. (some col.) ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g I.
|t Pathophysiology.
|g 1.
|t Basic Principles of Bone Physiology /
|r Stavros C. Manolagas, Robert S. Weinstein and Robert L. Jilka.
|g 2.
|t Humoral Hypercalcemia of Malignancy: The Discovery of PTHrP /
|r Vivian Grill, Wayne Rankin and T. John Martin.
|g 3.
|t Cellular and Molecular Mechanisms of Development of Skeletal Metastases /
|r Toshiyuki Yoneda, Paul J. Williams and Akira Myoi /
|r [et al.].
|g 4.
|t Pathogenesis of Osteoblastic Metastases /
|r David Goltzman and S. A. Rabbani --
|g II.
|t Clinical Aspects.
|g 5.
|t Clinical Aspects of Bone Metastases /
|r R. D. Rubens --
|g III.
|t Diagnosis and Monitoring.
|g 6.
|t Diagnosis and Monitoring of Bone Metastases: Clinical Means /
|r Martin Pecherstorfer and Michael Vesely.
|g 7.
|t Diagnosis and Monitoring of Bone Metastases: Scintigraphy /
|r Gary J. R. Cook and Ignac Fogelman.
|g 8.
|t Radiographic Diagnosis and Monitoring of Bone Metastases /
|r Michael Parsa and Mark D. Murphey.
|g 9.
|t Diagnosis and Monitoring of Bone Metastases: Serum Tumor Markers /
|r John Hilkens and Hans Bonfrer.
|g 10.
|t Markers of Bone Turnover in Diagnosis and Monitoring of Bone Metastases /
|r Aurelie Fontana, Patrick Garnero and Pierre D. Delmas --
|g IV.
|t Treatment of Bone Metastases: Classical Approach.
|g 11.
|t Treatment of Bone Metastases: Chemo- and Hormone Therapy /
|r Richard L. Theriault and Gabriel N. Hortobagyi.
|g 12.
|t Treatment of Bone Pain /
|r Rachel C. Koshy and Stuart A. Grossman.
|g 13.
|t Radiotherapy /
|r Peter J. Hoskin.
|g 14.
|t Palliation of Painful Bone Metastases: Radioactive Isotopes /
|r David F. Preston, Kirkman G. Baxter and Margi Schiefelbein /
|r [et al.].
|g 15.
|t Orthopedic Management of Skeletal Metastases /
|r Cynthia K. Rubert, Robert M. Henshaw and Martin M. Malawer --
|g V.
|t Treatment of Bone Metastases: Inhibitors of Osteoclastic Bone Resorption.
|g 16.
|t Bishosphonates: Introduction and Mechanisms of Action in Tumor Prevention /
|r Herbert A. Fleisch.
|g 17.
|t Clinical Pharmacology of Bisphosphonates /
|r R. Graham Russell, Peter J. Croucher and Michael J. Rogers.
|g 18.
|t Treatment of Tumor-Induced Hypercalcemia /
|r Stuart H. Ralston.
|g 19.
|t Treatment of Tumor-Induced Osteolysis and Prevention of Skeletal-Related Events in Patients with Bone Metastases /
|r Robert E. Coleman.
|g 20.
|t Prospects of Bisphosphonates for the Prevention of Bone Metastases /
|r Alexander H. G. Paterson.
|g 21.
|t Bisphosphonates in the Treatment of Multiple Myeloma /
|r John A. Kanis and Eugene V. McCloskey.
|g 22.
|t Gallium Nitrate and Bone Metastases /
|r Raymond P. Warrell, Jr. --
|g VI.
|t Osteoporosis in Patients with a History of Breast Cancer.
|g 23.
|t Osteoporosis in Patients with a History of Breast Cancer: Causes and Diagnosis /
|r Bent Winding, Henrik L. Jorgensen and Claus Christiansen.
|g 24.
|t Osteoporosis in Patients with a History of Breast Cancer Treated with Estrogen-Replacement Therapy /
|r Kathleen I. Pritchard.
|g 25.
|t Osteoporosis in Patients with a History of Breast Cancer: Bisphosphonates and Other Drugs /
|r D. Thiebaud and Peter Burckhardt.
|
| 650 |
|
0 |
|a Bone metastasis.
|0 http://id.loc.gov/authorities/subjects/sh90003139
|
| 650 |
|
0 |
|a Osteoporosis.
|0 http://id.loc.gov/authorities/subjects/sh85095984
|
| 650 |
|
0 |
|a Breast
|x Cancer
|x Complications.
|0 http://id.loc.gov/authorities/subjects/sh2010008528
|
| 650 |
1 |
2 |
|a Bone Neoplasms
|x secondary.
|
| 650 |
2 |
2 |
|a Breast Neoplasms
|x complications.
|
| 650 |
2 |
2 |
|a Diphosphonates
|x therapeutic use.
|
| 650 |
2 |
2 |
|a Osteolysis
|x drug therapy.
|
| 650 |
2 |
2 |
|a Osteoporosis
|x complications.
|
| 650 |
|
7 |
|a Bone metastasis.
|2 fast
|0 http://id.worldcat.org/fast/fst00835963
|
| 650 |
|
7 |
|a Breast
|x Cancer
|x Complications.
|2 fast
|0 http://id.worldcat.org/fast/fst01767179
|
| 650 |
|
7 |
|a Osteoporosis.
|2 fast
|0 http://id.worldcat.org/fast/fst01048817
|
| 700 |
1 |
|
|a Body, Jean-Jacques,
|d 1952-
|0 http://id.loc.gov/authorities/names/n99802419
|1 http://viaf.org/viaf/29706171
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)42073004
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 043a3d4f-3b52-54e3-9629-c66b213d73f0
|s 75f03f13-6aa3-5325-beef-0c89c7031961
|
| 928 |
|
|
|t Library of Congress classification
|a RC280.B6 T86 2000
|l ASR
|c ASR-SciASR
|i 4470473
|
| 927 |
|
|
|t Library of Congress classification
|a RC280.B6 T86 2000
|l ASR
|c ASR-SciASR
|e CRERAR
|b 55639531
|i 6718548
|
